Monday , October 23 2017
Home / Resources / Featured Writers (page 17)

Featured Writers

FEATURED WRITERS

Glucagon-like peptide 1 increases the period of postprandial satiety and slows gastric emptying in obese men

The regulation of food intake is a complex process involving psychologic, social, and physiologic components. Physiologically, it is generally assumed that food intake is regulated by a central feeding drive that is later counterregulated by peripheral satiety signals that are activated during a meal. These satiety signals have been suggested ...

Read More »

How Old Are You Really?

Sheri

By Sheri Colberg, PhD Different tissues and organs change over time at varying rates, so enhancing their function will likely slow your rate of biological aging and, in some cases, even reverse it. Certain biomarkers of biological aging can let you know whether you’re doing better or worse than your ...

Read More »

SPECIAL FEATURE: GLP-1 Agonist-based Therapies: An Emerging New Class of Antidiabetic Drug With Potential Cardioprotective Effects

alt

Melanie Sulistio, MD, Curtis Carothers, MD, Mandeep Mange, BS, Mike Lujan, BS, Rene Ofiveros, MD, and Robert Chilton, DO PART 2: GLP 1 Agonist-based Therapies: How do they reduce cardiovascular risks in diabetic patients? (For Part 1, just click here.) GLP-1 Agonist-based Therapies Reduce Cardiovascular Risk Weight loss is critical ...

Read More »

GLP-1 Agonist-based Therapies: An Emerging New Class of Antidiabetic Drug With Potential Cardioprotective Effects, Part 1

Image1

Melanie Sulistio, MD, Curtis Carothers, MD, Mandeep Mange, BS, Mike Lujan, BS, Rene Ofiveros, MD, and Robert Chilton, DO Cardiovascular disease is a leading cause of death in the United States and across the world, and better therapies are constantly being sought to improve patient outcomes. Recent studies have brought ...

Read More »

GLP-1’s Function in Preserving B-cells

GLP1sFunctioninPreservingBCells-Image

Associations between acute glucose lowering and improved acute insulin secretory responses suggest improved β-cell function. Comparing and assessing effects of pharmacological therapies used to control hyperglycemia on β-cell function is necessarily inferential, given lack of any universal measure.1

Read More »